Synthesis and biological evaluation of ferrocene-based cannabinoid receptor 2 ligands

Pojamide: An HDAC3-Selective Ferrocene Analogue with Remarkably Enhanced Redox-Triggered Ferrocenium Activity in Cells

(2017) Cory A. Ocasio et al.   ORGANOMETALLICS

The medicinal chemistry of ferrocene and its derivatives

(2017) Malay Patra et al.   Nature Reviews Chemistry

Design, synthesis and biological evaluation of potent FAAH inhibitors

(2016) Wei Tuo et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists

(2016) Mojgan Aghazadeh Tabrizi et al.   CHEMICAL REVIEWS

Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors

(2016) Wei Tuo et al.   JOURNAL OF MEDICINAL CHEMISTRY

High-resolution crystal structure of the human CB1 cannabinoid receptor

(2016) Zhenhua Shao et al.   NATURE

Synthesis of Bioorganometallic Nanomolar-Potent CB2 Agonists Containing a Ferrocene Unit

(2016) Supojjanee Sansook et al.   ORGANOMETALLICS

Targeting antioxidant pathways with ferrocenylated N-heterocyclic carbene supported gold(i) complexes in A549 lung cancer cells

(2016) J. F. Arambula et al.   Chemical Science

Ferrocifen type anti cancer drugs

(2015) Gérard Jaouen et al.   CHEMICAL SOCIETY REVIEWS

Switching cannabinoid response from CB2 agonists to FAAH inhibitors

(2014) Aurélien Tourteau et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Solvent-free Povarov reaction for synthesizing ferrocenyl quinolines: Antioxidant abilities deriving from ferrocene moiety

(2014) Gao-Lei Xi et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Peripheral gating of pain signals by endogenous lipid mediators

(2014) Daniele Piomelli et al.   NATURE NEUROSCIENCE

Synthesis of isoxazole moiety containing ferrocene derivatives and preliminarily in vitro anticancer activity

(2014) Jianping Yong et al.   MedChemComm

Ferrocene as a functional group enhances the inhibitive effect of dihydropyrimidine on radical-induced oxidation of DNA

(2014) Rui Wang et al.   Organic Chemistry Frontiers

3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis

(2013) Aurélien Tourteau et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Protein crystal structures with ferrocene and ruthenocene-based enzyme inhibitors

(2012) Adam J. Salmon et al.   CHEMICAL COMMUNICATIONS

New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis

(2011) Virginie Andrzejak et al.   BIOORGANIC & MEDICINAL CHEMISTRY

A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury

(2011) Bėla Horváth et al.   BRITISH JOURNAL OF PHARMACOLOGY

Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species

(2011) Helen Hagen et al.   JOURNAL OF MEDICINAL CHEMISTRY

Potential Applications of Ferrocene as a Structural Feature in Antioxidants

(2011) Zai-Qun Liu   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Unique pathway for anandamide synthesis and liver regeneration

(2011) A. A. Izzo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inhibition of titanium particle-induced inflammatory osteolysis through inactivation of cannabinoid receptor 2 by AM630

(2010) D. C. Geng et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Organometallic Anticancer Compounds

(2010) Gilles Gasser et al.   JOURNAL OF MEDICINAL CHEMISTRY

Anandamide Biosynthesis Catalyzed by the Phosphodiesterase GDE1 and Detection of Glycerophospho-N-acyl Ethanolamine Precursors in Mouse Brain

(2008) Gabriel M. Simon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Synthesis and Quantitative Structure−Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates

(2008) Marco Mor et al.   JOURNAL OF MEDICINAL CHEMISTRY

Biology and therapeutic potential of cannabinoid CB2receptor inverse agonists

(2007) C A Lunn et al.   BRITISH JOURNAL OF PHARMACOLOGY